Zepp Health Corporation provided revenue guidance for the fourth quarter of 2022. For the quarter, the company expects net revenues to be between RMB 1.1 billion to RMB 1.35 billion, compared with RMB 1.66 billion in the fourth quarter of 2021. This outlook reflects continued uncertainty pertaining to the potential effects of the COVID-19 pandemic on sales and on electronic component delays, as well as the expected sales seasonality of both self-branded and Xiaomi products.

It is based on current market conditions and reflects the Company's current and preliminary estimates of market and operating conditions and customer demand, which are all subject to change.